RecruitingNot ApplicableNCT05107947

Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian Rhythm


Sponsor

Region Skane

Enrollment

300 participants

Start Date

Oct 31, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this project is to evaluate the effect of a dynamic light in order to improve the circadian rhythm, provide a better sleep and well-being, and in the long run an improved recovery. The primary question is whether dynamic artificial light with circadian stimulus can affect the circadian rhythm. The secondary question is whether this also provides better sleep and well-being. The group that is particularly interesting to study is a geriatric population that is more sensitive to circadian rhythm disorders, sleep disorders and confusion in connection with hospitalization and that can be of particular benefit from this intervention.


Eligibility

Min Age: 65 Years

Inclusion Criteria2

  • Over the age of 65 years
  • Admitted to one of the included study rooms

Exclusion Criteria12

  • Overdose addictive substance
  • Acute neurological disease
  • Melatonin treatment
  • Probable survival \<5 days
  • Severe visual impairment that makes reading impossible
  • Age \<65 years
  • Inability to understand Swedish in speech and writing
  • Inability to consent to participate in the study
  • The patient is on any of the following medicines:
  • Medications for Parkinson's disease
  • Neuroleptics (including lithium)
  • Dementia

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiocentric light

Light that changes in intensity and spectral distribution during the day to mimick daylight. High in intensity and high circadian stimulus during daytime and low intensity and low circadian stimulus during late afternoon and night.


Locations(1)

Skåne University Hospital Malmö

Malmo, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05107947


Related Trials